61 related articles for article (PubMed ID: 38510490)
1. Disruption of polyunsaturated fatty acid biosynthesis drives STING-dependent acute myeloid leukemia cell maturation and death.
Kanefsky J; Basse M; Sokei J; di Martino O; Valin L; Jaspers Y; Martinez E; Huhn J; Di Marcantonio D; Magee JA; Goldman AR; Tang HY; Ferraro F; Kemp S; Wiest DL; Sykes SM
J Biol Chem; 2024 May; 300(5):107214. PubMed ID: 38522521
[TBL] [Abstract][Full Text] [Related]
2. Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice.
Sampaio LR; Dias RDB; Goes JVC; de Melo RPM; de Paula Borges D; de Lima Melo MM; de Oliveira RTG; Ribeiro-Júnior HL; Magalhães SMM; Pinheiro RF
Med Oncol; 2024 Apr; 41(6):128. PubMed ID: 38656461
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of cGAS and STING gene expression in acute myeloid leukemia.
Chen Q; Hong Y; Chen W; Lin F; Zeng J; Huang Y; Zhang L; Yao J; Xu B
Exp Biol Med (Maywood); 2024; 249():10108. PubMed ID: 38510490
[TBL] [Abstract][Full Text] [Related]
4. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
[TBL] [Abstract][Full Text] [Related]
8. NRF2 participates in the suppressive tumor immune microenvironment of KRAS/KEAP1 co-mutant non-small cell lung cancer by inhibiting the STING pathway.
Xiaodan S; Peiyan Z; Hui L; Yan L; Ying C
Genes Dis; 2023 Sep; 10(5):1727-1730. PubMed ID: 37492744
[No Abstract] [Full Text] [Related]
9. The stimulator of interferon genes (STING) agonists for treating acute myeloid leukemia (AML): current knowledge and future outlook.
Song X; Peng Y; Wang X; Chen Q; Lan X; Shi F
Clin Transl Oncol; 2023 Jun; 25(6):1545-1553. PubMed ID: 36587109
[TBL] [Abstract][Full Text] [Related]
10. Activating STING1-dependent immune signaling in
Kogan AA; Topper MJ; Dellomo AJ; Stojanovic L; McLaughlin LJ; Creed TM; Eberly CL; Kingsbury TJ; Baer MR; Kessler MD; Baylin SB; Rassool FV
Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2123227119. PubMed ID: 35759659
[TBL] [Abstract][Full Text] [Related]
11. SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis.
Song C; Liu D; Liu S; Li D; Horecny I; Zhang X; Li P; Chen L; Miller M; Chowdhury R; Issa M; Shen R; Yan Y; Zhang F; Zhang L; Zhang L; Bai C; Feng J; Zhuang L; Zhang R; Li J; Wilkinson H; Liu J; Tao W
Sci Rep; 2022 May; 12(1):8579. PubMed ID: 35595822
[TBL] [Abstract][Full Text] [Related]
12. cGAS-STING pathway expression as a prognostic tool in NSCLC.
Raaby Gammelgaard K; Sandfeld-Paulsen B; Godsk SH; Demuth C; Meldgaard P; Sorensen BS; Jakobsen MR
Transl Lung Cancer Res; 2021 Jan; 10(1):340-354. PubMed ID: 33569317
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
